{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:33:15Z","timestamp":1778589195843,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10753-007-9054-y","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T18:06:06Z","timestamp":1199901966000},"page":"99-104","source":"Crossref","is-referenced-by-count":19,"title":["Serum Matrix Metalloproteinase-2 Levels Indicate Blood\u2013CSF Barrier Damage in Patients with Infectious Meningitis"],"prefix":"10.1007","volume":"31","author":[{"given":"Yuhsaku","family":"Kanoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motonari","family":"Kanoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,10]]},"reference":[{"issue":"2","key":"9054_CR1","doi-asserted-by":"crossref","first-page":"245\u2013","DOI":"10.1016\/0022-510X(84)90173-4","volume":"64","author":"P. Livrea","year":"1984","unstructured":"Livrea, P., M. Trojano, L. I. Simone, B. G. Zimatore, L. Pisicchiro, G. Longrocino, and G. Cigelli. 1984. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid\/serum protein concentration gradients. J. Neurol. Sci 64:2p. 245\u2013258.","journal-title":"J. Neurol. Sci"},{"key":"9054_CR2","doi-asserted-by":"crossref","first-page":"385\u2013","DOI":"10.3109\/00365517709091496","volume":"37","author":"G. Tibbling","year":"1977","unstructured":"Tibbling, G., H. Link, and S. Ohman. 1977. Principles of albumin and IgG analyses in neurological disorder. I. Establishment of reference values. Scand. J Clin. Lab. Invest 37:385\u2013390.","journal-title":"Scand. J Clin. Lab. Invest"},{"key":"9054_CR3","doi-asserted-by":"crossref","first-page":"391\u2013","DOI":"10.3109\/00365517709091497","volume":"37","author":"H. Link","year":"1977","unstructured":"Link, H., and G. Tibbing. 1977. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand. J. Clin. Lab. Invest 37:391\u2013396.","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"9054_CR4","doi-asserted-by":"crossref","first-page":"73\u2013","DOI":"10.1016\/0022-510X(93)90248-W","volume":"118","author":"G. Meucci","year":"1993","unstructured":"Meucci, G., G. Rossi, R. Bettini, D. Montanaro, L. Gironelli, L. Voci, and F. Bianchi. 1993. Laser-nepherometric evaluation of albumin, IgG and \u03b12 macroglobulin: applications of the study of alterations of the blood\u2013brain barrier. J. Neurol. Sci 118:73\u201378.","journal-title":"J. Neurol. Sci"},{"key":"9054_CR5","doi-asserted-by":"crossref","first-page":"709\u2013","DOI":"10.1042\/bj1330709","volume":"133","author":"A. Barrett","year":"1973","unstructured":"Barrett, A., and P. M. Starkey. 1973. The interaction of \u03b12 macroglobulin with proteases. Biochem. J 133:709\u2013724.","journal-title":"Biochem. J"},{"issue":"2","key":"9054_CR6","first-page":"269\u2013","volume":"43","author":"Y. Kanoh","year":"1997","unstructured":"Kanoh, Y., and H. Ohtani. 1997. Levels of interleukin-6, CRP and \u03b12 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage. Biochem. Mol. Bio. Int 43(2):269\u2013278.","journal-title":"Biochem. Mol. Bio. Int"},{"key":"9054_CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1097-0045(19970801)32:3<196::AID-PROS6>3.0.CO;2-J","volume":"32","author":"P. H. A. Quax","year":"1997","unstructured":"Quax, P. H. A., A. C. W. Bart de, K. A. Schalken, and I. H. Verheijen. 1997. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vivo: correlation with metastatic behavior in vivo. Prostate 32:196\u2013204.","journal-title":"Prostate"},{"key":"9054_CR8","first-page":"1856","volume":"55","author":"C. K. Elise","year":"1995","unstructured":"Elise, C. K., and A. L. Lance. 1995. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer 55:1856\u20131862.","journal-title":"Cancer"},{"issue":"4","key":"9054_CR9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10016-005-5018-6","volume":"19","author":"D. N. Tziakas","year":"2005","unstructured":"Tziakas, D. N., M. K. Lazarides, I. K. Tentes, G. S. Georgiadis, E. Eleftheriadou, G. K. ChaliKias, A. Kortsaris, and D. I. Hatseras. 2005. Gelatinases (matrix metalloproteinase-2 (MMP-2) and MMP-9) induce carotid plaque instability but their systemic levels are not predictive of local events. Ann. Vasc. Surg 19(4):529\u2013533.","journal-title":"Ann. Vasc. Surg"},{"issue":"5A","key":"9054_CR10","first-page":"3579","volume":"26","author":"H. Zheng","year":"2006","unstructured":"Zheng, H., H. Takahashi, Y. Murai, Z. Cui, K. Nomoto, H. Niwa, K. Tsuneyama, and Y. Takano. 2006. Expression of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26(5A):3579\u20133583.","journal-title":"Anticancer Res"},{"key":"9054_CR11","first-page":"1813","volume":"22","author":"Y. Kanoh","year":"2002","unstructured":"Kanoh, Y., T. Akahoshi, T. Ohara, N. Ohtani, T. Mashiko, S. Ohtani, S. Egawa, and S. Baba. 2002. Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer. Anticancer Res 22:1813\u20131817.","journal-title":"Anticancer Res"},{"key":"9054_CR12","doi-asserted-by":"crossref","first-page":"73-","DOI":"10.1016\/0022-510X(93)90248-W","volume":"118","author":"G. Meucci","year":"1993","unstructured":"Meucci, G., G. Rossi, R. Bettini, D. Montanaro, L. Gironelli, L. Voci, and F. Bianchi. 1993. Laser-nepherometric evaluation of albumin, IgG and \u03b12 macroglobulin: applications to the study of alterations of the blood\u2013brain barrier. J. Neurol. Sci 118:73\u201378.","journal-title":"J. Neurol. Sci"},{"issue":"2","key":"9054_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.braindev.2006.06.008","volume":"29","author":"Y. Otaka","year":"2007","unstructured":"Otaka, Y., T. Yamagata, Y. Morimoto, M. Imi, M. Mori, T. Aihara, T. Ichiyama, and M. Y. Momoi. 2007. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev 29(2):117\u2013120.","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"9054_CR14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2007.01.002","volume":"185","author":"M. D. Chapman","year":"2007","unstructured":"Chapman, M. D., E. J. Thompson, P. M. Candler, R. C. Dale, A. J. Church, and G. Giovannoni. 2007. Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting. J. Neuroimmunol 185(1\u20132):130\u2013135.","journal-title":"J. Neuroimmunol"},{"issue":"1","key":"9054_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(99)00303-2","volume":"173","author":"E. Matsuura","year":"2000","unstructured":"Matsuura, E., F. Umehara, T. Hashiguchi, N. Fujimoto, Y. Okada, and M. Osame. 2000. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J. Neurol. Sci 173(1):45\u201352.","journal-title":"J. Neurol. Sci"},{"issue":"1\u20132","key":"9054_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(03)00006-7","volume":"136","author":"C. Avolio","year":"2003","unstructured":"Avolio, C., M. Ruggier, F. Giuliani, G. M. Liuzzi, R. Leante, P. Riccio, P. Livrea, and M. Trojano. 2003. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J. Neuroimmunol 136(1\u20132):46\u201353.","journal-title":"J. Neuroimmunol"},{"issue":"5","key":"9054_CR17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO;2-2","volume":"82","author":"M. H. Friedberg","year":"2003","unstructured":"Friedberg, M. H., M. J. Glantz, M. S. Klempner, B. F. Cole, and G. Perides. 2003. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 82(5):923\u2013930.","journal-title":"Cancer"},{"key":"9054_CR18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(83)90157-0","volume":"60","author":"I. Alafuzoff","year":"1983","unstructured":"Alafuzoff, I., R. Adolfson, G. Bucht, and B. Winblad. 1983. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood\u2013cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J. Neurol. Sci 60:465\u2013472.","journal-title":"J. Neurol. Sci"},{"key":"9054_CR19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","volume":"252","author":"J. Brettschneider","year":"2005","unstructured":"Brettschneider, J., A. Claus, J. Kassubek, and H. Tumani. 2005. Isolated blood\u2013cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J. Neurol 252:1067\u20131073.","journal-title":"J. Neurol"},{"issue":"1","key":"9054_CR20","first-page":"551\u2013","volume":"21","author":"Y. Kanoh","year":"2001","unstructured":"Kanoh, Y., N. Ohtani, T. Nishikawa, T. Mashiko, S. Ohtani, S. Egawa, S. Baba, and H. Ohtani. 2001. Levels of \u03b12 macroglobulin can predict bone metastases in prostate cancer. Anticancer Res 21(1):551\u2013556.","journal-title":"Anticancer Res"},{"key":"9054_CR21","first-page":"515\u2013","volume":"8","author":"Y. Kanoh","year":"2001","unstructured":"Kanoh, Y., N. Ohtani, T. Ohhara, T. Mashiko, S. Ohtani, S. Egawa, S. Baba, and H. Ohtani. 2001. Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, \u03b12 macroglobulin and their complexes. Oncol. Rep 8:515\u2013519.","journal-title":"Oncol. Rep"},{"key":"9054_CR22","first-page":"25\u2013","volume":"40","author":"Y. Kanoh","year":"1996","unstructured":"Kanoh, Y., K. Ichikawa, S. Jimbo, Y. Shimura, K. Hachimura, and H. Ohtani. 1996. Protein abnormalities in CSF and blood under blood\u2013cerebrospinal fluid barrier damage. Jpn. J. Electrophor 40:25\u201332.","journal-title":"Jpn. J. Electrophor"},{"key":"9054_CR23","doi-asserted-by":"crossref","first-page":"171\u2013","DOI":"10.1007\/BF00312558","volume":"207","author":"G. Schlip","year":"1974","unstructured":"Schlip, G., and K. Felgenhauer. 1974. The \u03b12 macroglobulin levels in cerebrospinal fluid; a parameter for the condition of the blood\u2013CSF barrier. J. Neurol 207:171\u2013181.","journal-title":"J. Neurol"},{"key":"9054_CR24","doi-asserted-by":"crossref","first-page":"2858\u2013","DOI":"10.1161\/01.STR.0000038098.04291.F6","volume":"33","author":"B. Axisa","year":"2002","unstructured":"Axisa, B., M. I. Loftus, R. A. Naylor, S. Goodall, L. Jones, F. R. P. Bell, and M. M. Thompson. 2002. Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke 33:2858\u20132865.","journal-title":"Stroke"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-007-9054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-007-9054-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-007-9054-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T23:37:58Z","timestamp":1559259478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-007-9054-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9054"],"URL":"https:\/\/doi.org\/10.1007\/s10753-007-9054-y","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,10]]}}}